OSL secures new distribution agreement with IBA Dosimetry

Posted on Jul 09, 2013

Oncology Systems Limited (OSL), the UK's largest independent provider of radiotherapy equipment in the UK, has today been awarded a new contract to exclusively distribute IBA's advanced radiation therapy dosimetry solutions throughout the UK and Ireland.

Stuart Baldwin, OSL’s newly appointed Managing Director, said: “The IBA Dosimetry portfolio offers our customers advanced radiation therapy treatment verification and quality assurance solutions that enable the latest delivery techniques to be assessed and realised. Feedback from customers is extremely positive in relation to the ease of use and accuracy of these solutions and their overall satisfaction with IBA developments. We are very much looking forward to the new relationship and building on the good work that has been done here over several years”.

José Luis Roldán de Llano, EMEA Sales Director for IBA Dosimetry, said: “OSL will be an important partner for IBA as we seek to bring the best radiation therapy quality assurance tools and processes to our customers in the UK & Ireland. We are pleased to welcome our partnership with OSL and look forward to sustained momentum in the region along with continuity in outstanding local customer support and training”.


This page was printed from OSL Web site at http://www.osl.uk.com